Study on Exercise Safety of Patients With Cardiovascular Diseases
Sponsor
Peking University Third Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04963478
Collaborator
(none)
100
Enrollment
1
Location
3
Anticipated Duration (Months)
33.1
Patients Per Site Per Month
Study Details
Study Description
Brief Summary
To retrospectively observe the cardiovascular safety during exercise in patients with cardiovascular diseases
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
100 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Study on Exercise Safety of Patients With Cardiovascular Diseases
Anticipated Study Start Date
:
Aug 1, 2021
Anticipated Primary Completion Date
:
Oct 1, 2021
Anticipated Study Completion Date
:
Nov 1, 2021
Outcome Measures
Primary Outcome Measures
- exercise-related cardiovascular events [3 months]
Eligibility Criteria
Criteria
Ages Eligible for Study:
19 Years
to 90 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
Patients with confirmed or suspected cardiovascular disease who completed the trial
Exclusion Criteria:
Refusing to participate in the study
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Wei Zhao | Beijing | Beijing | China | 100191 |
Sponsors and Collaborators
- Peking University Third Hospital
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Peking University Third Hospital
ClinicalTrials.gov Identifier:
NCT04963478
Other Study ID Numbers:
- IRB00006761-M2020073
First Posted:
Jul 15, 2021
Last Update Posted:
Jul 15, 2021
Last Verified:
Jun 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:
